Detalhe da pesquisa
1.
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.
Lancet Oncol
; 24(5): 443-456, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142371
2.
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
Lancet
; 399(10323): 447-460, 2022 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34953525
3.
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
N Engl J Med
; 381(16): 1535-1546, 2019 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31562797
4.
Cytoreductive nephrectomy and exposure to sunitinib - a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial.
BJU Int
; 130(1): 68-75, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34706141
5.
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial.
Lancet
; 395(10232): 1268-1277, 2020 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32145825
6.
Recombination hotspots in an extended human pseudoautosomal domain predicted from double-strand break maps and characterized by sperm-based crossover analysis.
PLoS Genet
; 14(10): e1007680, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30296256
7.
Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial.
Cancer
; 126(18): 4156-4167, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32673417
8.
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
N Engl J Med
; 377(14): 1345-1356, 2017 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28889792
9.
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
N Engl J Med
; 377(4): 338-351, 2017 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28578639
10.
Epstein-Barr Virus-Positive Mucocutaneous Ulcers Complicate Colitis Caused by Immune Checkpoint Regulator Therapy and Associate With Colon Perforation.
Clin Gastroenterol Hepatol
; 18(8): 1785-1795.e3, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31610336
11.
Extracting data from a chemotherapy prescription platform for real-world oncology research in the UK: a pilot study.
Future Oncol
; 15(21): 2471-2477, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31161801
12.
Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial.
Lancet Oncol
; 19(11): 1480-1492, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30361170
13.
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.
N Engl J Med
; 373(19): 1803-13, 2015 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26406148
14.
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
N Engl J Med
; 373(1): 23-34, 2015 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26027431
15.
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
Lancet
; 387(10024): 1163-77, 2016 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26719232
16.
Improved Disease-Free Survival With Adjuvant Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Cancer: Final Results of the POUT Trial.
J Clin Oncol
; 42(13): 1466-1471, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38350047
17.
A corpus of GA4GH Phenopackets: case-level phenotyping for genomic diagnostics and discovery.
medRxiv
; 2024 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38854034
18.
Transduction-specific ATLAS reveals a cohort of highly active L1 retrotransposons in human populations.
Hum Mutat
; 34(7): 974-85, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23553801
19.
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial.
J Clin Oncol
; 41(11): 1957-1964, 2023 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37018920
20.
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma.
J Clin Oncol
; 40(2): 127-137, 2022 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34818112